Login



Sporadic Neurodegeneration

Genes, Environment and Therapeutic Strategies

july 31-august 01, 2008
boston, massachusetts, usa

Call for Abstracts

SAVE THE DATE

 

Much progress has been made in identifying genes involved in familial, or inherited, forms of different neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and Amyotrophic Lateral Sclerosis (ALS). Although the majority of these disease cases are sporadic (not inherited), the origin(s) of sporadic neurodegeneration remain undetermined. We have designed this course to recognize and evaluate the current hypotheses surrounding sporadic pathogenesis. Gene candidates, including several recently revealed through Whole Genome Analyses (WGA), that are common and distinct between sporadic and familial diseases will be presented. Putative susceptibility factors for sporadic diseases, such as environmental insults and epigenetic alterations, will be described in the context of epidemiological analysis and experimental biology. We will bring together a panel of expert neuroscientists to dissertate on the future direction of neurodegenerative disease research, with a focus on advancing novel and appropriate therapies for both sporadic and familial diseases.

This program facilitates the full engagement of junior investigators (students, post-docs, fellows, technicians, instructors and lecturers) by offering ample opportunities for networking, interacting with senior faculty and discussing mutual research and clinical interests. The Angel Fund Junior Investigator Awards will be given to the lead authors of the most outstanding poster abstracts adjudicated by an expert panel.

 

Submit an abstract for poster presentation and save $50 on the registration fee! The $50 discount will be applied to your registration after your abstract is received by BioSymposia. Travel awards are being offered to junior investigators. Attendees who wish to be considered for The Angel Fund Junior Investigator Award must submit an abstract for poster presentation. Junior investigators working for commercial entities (pharmaceutical, biotechnology, device manufacturers) or affiliated with the institution of the scientific committee are not eligible to receive travel awards but will be considered for recognition. The deadline for abstract submission is June 27, 2008.

Angel Fund Logo

 

Check back for updated information.

home
about us
calendar
conferences
online courses
contact us
site map
legal
privacy

BioSymposia, Inc. is accredited by the Accreditation Council for Continuing Medical Education, the American Nurses Association's American Nurses Credentialing Center, and the Accreditation Council for Pharmacy Education. We also work with other key accreditors.

This site contains medical information and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

© 2008 BioSymposia, Inc., All rights reserved.

register nowinvite a
colleague
customer
service
chairs/speakers
scientific
committee
submit an
abstract
Log in/Register